Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- New Facility for Puresource and NOW Foods
The 11,000 sq ft plant has been developed to meet the current requirements for Natural Health Products Good Manufacturing Practices; Products marketed under the Herbal Select and NOW brands will be produced in this facility.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
SALT LAKE CITY, Oct 28, 2005 (BUSINESS WIRE) -- Weider Nutrition International, Inc. (WNI) today announced its formal name change to Schiff Nutrition International, Inc. Shareholders approved the name change at the company's annual meeting held October 25th in Salt Lake City, Utah. The company will begin trading under its new name on the New York Stock Exchange on November 1, 2005, but will retain its current New York Stock Exchange symbol: WNI. Bruce Wood, president and chief executive officer, stated, "With the recent divestitures of the Weider(R) brand business and the Germany-based Haleko business unit, we have streamlined our business portfolio, and are now dedicating our resources to our growing Schiff(R) branded business, which represents the vast majority of our revenues."
Wood added, "The Schiff brand is a recognized premium brand in the nutritional supplements arena, and it is appropriate that our new corporate name reflects our strategic commitment to growing the Schiff brand. Looking ahead, we expect to leverage our existing Schiff business, invest in new product initiatives under the Schiff brand umbrella, and explore acquisition opportunities that fit strategically and operationally with our Schiff business."
Stockholders also approved the re-election of Eric Weider, George F. Lengvari, Bruce J. Wood, Ronald L. Corey, Roger H. Kimmel, Brian P. McDermott and H. F. Powell to the board of directors for terms ending upon the election of directors at the 2006 annual stockholders meeting. The board currently consists of seven directors who are elected annually.
About Schiff Nutrition
Schiff Nutrition International, Inc. (formerly Weider Nutrition International) develops, manufactures, markets and sells branded and private label vitamins, nutritional supplements and sports nutrition products in the United States and throughout the world. To learn more about Schiff, please visit the Web site www.schiffnutrition.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended, that are based on management's beliefs and assumptions, current expectations, estimates, and projections. These statements are subject to risks and uncertainties, certain of which are beyond the company's ability to control or predict, and, therefore, actual results may differ materially. Schiff Nutrition disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.
Important factors that may cause these forward-looking statements to be false include, but are not limited to: the inability to successfully implement marketing and spending programs behind our Move Free brand and other branded new products, the impact of raw material pricing and availability (particularly relating to joint care products), the inability to achieve cost savings and operational efficiencies, the inability to increase operating margins and increase revenues, dependence on individual products, dependence on individual customers, the impact of competitive products and pricing (including private label), market and industry conditions (including pricing, demand for products and level of trade inventories), the impact of clinical studies regarding nutritional supplements, particularly relating to the joint care category, the success of product development, the inability to obtain customer acceptance of new product introductions, changes in laws and regulations, litigation and government regulatory action, uncertainty of market acceptance of new products, adverse publicity regarding the consumption of nutritional supplements, the inability to find strategic acquisitions or the inability to successfully consummate or integrate an acquisition, changes in accounting standards, and other factors indicated from time to time in the company's SEC reports, copies of which are available upon request from the company's investor relations department or may be obtained at the SEC's website (www.sec.gov). |